138 related articles for article (PubMed ID: 16061845)
1. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment.
Epstein RJ
Clin Cancer Res; 2005 Aug; 11(15):5337-41. PubMed ID: 16061845
[TBL] [Abstract][Full Text] [Related]
2. Tumor dormancy and metastasis.
Hedley BD; Chambers AF
Adv Cancer Res; 2009; 102():67-101. PubMed ID: 19595307
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
4. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
Myhr G
Med Hypotheses; 2008; 70(3):665-70. PubMed ID: 17765401
[TBL] [Abstract][Full Text] [Related]
5. Cancer metastasis: a search for therapeutic inhibition.
Dimitroff CJ; Sharma A; Bernacki RJ
Cancer Invest; 1998; 16(4):279-90. PubMed ID: 9589037
[TBL] [Abstract][Full Text] [Related]
6. [Principles of drug therapy of malignant tumors: the role of malignant progression in the choice of effective drugs].
Jeney A; Rosta A
Orv Hetil; 1999 May; 140(22):1245-9. PubMed ID: 10377736
[TBL] [Abstract][Full Text] [Related]
7. Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy.
Zhuang SH; Xiu L; Elsayed YA
Cancer J; 2009; 15(5):395-400. PubMed ID: 19826359
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of solid tumours].
Buter J
Ned Tijdschr Tandheelkd; 2008 Apr; 115(4):201-2. PubMed ID: 18512518
[TBL] [Abstract][Full Text] [Related]
9. [Tumor dormancy therapy--what do you think of this therapy?].
Sasaki T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):1949-54. PubMed ID: 11791373
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
Dellinger TH; Monk BJ
Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for breast cancer.
Hennessy BT; Pusztai L
Minerva Ginecol; 2005 Jun; 57(3):305-26. PubMed ID: 16166938
[TBL] [Abstract][Full Text] [Related]
12. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
Garay RP; Viens P; Bauer J; Normier G; Bardou M; Jeannin JF; Chiavaroli C
Eur J Pharmacol; 2007 Jun; 563(1-3):1-17. PubMed ID: 17383632
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
14. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
Hogberg T
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
[TBL] [Abstract][Full Text] [Related]
16. Targeting angiogenesis with integrative cancer therapies.
Yance DR; Sagar SM
Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
[TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
Moreau JP; Delavault P; Blumberg J
Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109
[TBL] [Abstract][Full Text] [Related]
18. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
19. Pathologic response to preoperative therapy: does it mean what we think it means?
Mansour JC; Schwarz RE
Ann Surg Oncol; 2009 Jun; 16(6):1465-79. PubMed ID: 19326170
[TBL] [Abstract][Full Text] [Related]
20. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
